Literature DB >> 30742580

Subclinical hypothyroidism: When to treat.

Sidra Azim1,2,3, Christian Nasr4,5.   

Abstract

Subclinical hypothyroidism is defined by an elevated serum thyroid-stimulating hormone (TSH) level along with a normal free thyroxine (T4) level. Whether it should be treated remains controversial. Currently, the best practical approach is to base treatment decisions on the degree of TSH elevation, thyroid autoimmunity, and associated comorbidities.
Copyright © 2019 Cleveland Clinic.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30742580     DOI： 10.3949/ccjm.86a.17053

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  3 in total

Review 1.  Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions.

Authors:  Nadia Sawicka-Gutaj; Natalia Zawalna; Paweł Gut; Marek Ruchała
Journal:  Pharmacol Rep       Date:  2022-06-30       Impact factor: 3.919

2.  Serum retinol-binding protein 4 is associated with the presence and severity of coronary artery disease in patients with subclinical hypothyroidism.

Authors:  Hui-Xian Sun; Hui-Hong Ji; Xiao-Lin Chen; Li Wang; Yue Wang; Xi-Yu Shen; Xiang Lu; Wei Gao; Lian-Sheng Wang
Journal:  Aging (Albany NY)       Date:  2019-07-06       Impact factor: 5.682

3.  Editorial: Subclinical thyroid disease: present knowledge and future direction.

Authors:  Jose De Jesus Garduno Garcia; Alberto O Chavez; Daniel Elías-López; Iván Pérez-Díaz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-21       Impact factor: 6.055
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.